StockData

Incannex Healthcare vs Silo Pharma

IXHL and SILO side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How IXHL and SILO compare

Incannex Healthcare is the larger company, worth 8.0 times as much as Silo Pharma ($21.8M against $2.7M).

Incannex Healthcare scores higher on the StockData Score (7 against 2 for Silo Pharma), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricIXHLSILO
Size and price
Market cap$21.8M$2.7M
Share price$1.74$1.71
Change, 1 year−83.5%−72.4%
Change, 5 years–−98.8%
Beta (5Y)2.402.90
Employees123
StockData Score
Total score7 (better)2
Valuation score11
Growth score00
Performance score1 (better)0
Health score5 (better)1
Dividend score00
Valuation
P/S–50.2×
P/B0.3× (better)0.6×
FCF yield−14.6%–
Growth
Revenue growth (TTM)–−25.0%
Revenue growth, 5Y average–12.0%
Profitability
Gross margin–−14.8%
Operating margin–−8250%
Net margin–−8270%
Return on equity−20.7% (better)−91.2%
Return on invested capital−1945%–
Financial health
Debt / equity0.00–
Interest coverage–−112.0×
Current ratio67.79 (better)5.36
Altman Z-score−0.22 (better)−5.17
Piotroski F-score44
Dividends and buybacks
Buyback yield−42.2%–
Shareholder yield−42.2%0.00% (better)
Ownership
Held by institutions3.6%9.0%
Held by insiders–13.8%
Insider net buying, 12 months–$2.1K
Short interest, % of float–1.0%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.